StockNews.com Begins Coverage on Natural Alternatives International (NASDAQ:NAII)

Posted by ABMN Staff on Nov 26th, 2024

Investment analysts at StockNews.com began coverage on shares of Natural Alternatives International (NASDAQ:NAII – Get Free Report) in a note issued to investors on Tuesday. The brokerage set a “buy” rating on the stock.

Natural Alternatives International Trading Up 2.4 %

NAII opened at $4.31 on Tuesday. The firm has a market cap of $26.72 million, a P/E ratio of -2.99 and a beta of 0.58. The company has a current ratio of 2.56, a quick ratio of 1.50 and a debt-to-equity ratio of 0.11. The stock has a 50-day moving average of $4.96 and a 200 day moving average of $5.65. Natural Alternatives International has a 12 month low of $4.11 and a 12 month high of $7.37.

Natural Alternatives International (NASDAQ:NAII – Get Free Report) last posted its quarterly earnings data on Friday, September 27th. The company reported ($0.32) earnings per share for the quarter. Natural Alternatives International had a negative return on equity of 10.23% and a negative net margin of 7.53%. The firm had revenue of $29.49 million during the quarter.

Institutional Trading of Natural Alternatives International

A hedge fund recently raised its stake in Natural Alternatives International stock. Geode Capital Management LLC grew its holdings in Natural Alternatives International, Inc. (NASDAQ:NAII – Free Report) by 6.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 45,062 shares of the company’s stock after purchasing an additional 2,915 shares during the quarter. Geode Capital Management LLC owned approximately 0.73% of Natural Alternatives International worth $258,000 at the end of the most recent reporting period. 32.40% of the stock is currently owned by institutional investors and hedge funds.

About Natural Alternatives International

(Get Free Report)

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.